Detalhe da pesquisa
1.
4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies.
Bioorg Chem
; 107: 104577, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33450542
2.
Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
Cancer Immunol Immunother
; 68(3): 529, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721340
3.
CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
Cancer Immunol Immunother
; 68(3): 467-478, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30607549
4.
PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.
J Allergy Clin Immunol
; 135(6): 1578-88.e5, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25842288
5.
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Sci Transl Med
; 16(731): eadd1834, 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266104
6.
Breast cancer-derived transforming growth factor-ß and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.
Int J Cancer
; 133(3): 771-8, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23389942
7.
Second-Generation CD73 Inhibitors Based on a 4,6-Biaryl-2-thiopyridine Scaffold.
ChemMedChem
; 18(7): e202200594, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700491
8.
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.
Breast Cancer (Dove Med Press)
; 15: 311-325, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139242
9.
MDR1-EXPRESSING CD4+ T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSE.
J Immunother Cancer
; 11(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940345
10.
Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial.
BMJ Open
; 12(4): e056819, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35393316
11.
Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer.
Eur J Cancer
; 169: 106-122, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550950
12.
C/EBP{delta} and STAT-1 are required for TLR8 transcriptional activity.
J Biol Chem
; 285(45): 34773-80, 2010 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20829351
13.
Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.
BMC Cancer
; 11: 213, 2011 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21624121
14.
Recruitment and Expansion of Tregs Cells in the Tumor Environment-How to Target Them?
Cancers (Basel)
; 13(8)2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33924428
15.
Serum cytokines in follicular lymphoma. Correlation of TGF-ß and VEGF with survival.
Ann Hematol
; 89(1): 25-33, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19582455
16.
CD163+ tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes.
Clin Transl Immunology
; 9(2): e1108, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32082570
17.
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
J Immunother Cancer
; 7(1): 85, 2019 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922400
18.
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.
Front Immunol
; 10: 925, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31244820
19.
Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production.
J Clin Med
; 8(11)2019 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31684171
20.
A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system.
Oncoimmunology
; 8(7): 1596005, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31143518